Why are patients split at random?
- To save paperwork
- To scrub hidden differences like age or lifestyle
- To please the drug maker
What is a placebo?
- A smaller dose of the drug
- An identical-looking dummy with nothing in it
- A different drug
Without a placebo group, a mindset boost can look like drug chemistry.
Circle one: True False
Why blind the patients to their group?
- So all groups expect the same benefit and behave the same way
- So they sleep better
- So they never meet doctors
What does a placebo rule out, and what does it leave open?
- It rules out expectation but not observer bias
- It rules out everything at once
- It rules out nothing at all
Why double blind instead of stopping at single blind?
- It uses twice the pills
- Researchers stay unaware too, blocking unequal care and biased reading
- It shortens the trial
A drug shines in 20 healthy volunteers and the maker seeks prescriptions now. What remains?
- A new name for the pill
- Nothing: small safety success is enough
- Large efficacy trials in hundreds or thousands, then monitoring after approval
A survey links coffee to sharper memory and a maker claims proof. What is missing?
- A bigger survey
- An experiment that assigns the treatment with a control group
- A louder claim
Testing drugs without fooling yourself W1-mt_If6qHIrOxT-s1
- To scrub hidden differences like age or lifestyle · Random splits leave the drug as the only systematic difference.
- An identical-looking dummy with nothing in it · The dummy shows what recovery without the drug looks like.
- True · Expectation alone moves bodies, so trials must subtract it.
- So all groups expect the same benefit and behave the same way · Equal expectations keep behaviour from becoming a second treatment.
- It rules out expectation but not observer bias · Equal belief is handled, while researcher-side bias needs blinding.
- Researchers stay unaware too, blocking unequal care and biased reading · Single blinding leaves a researcher-shaped gap that double blinding closes.
- Large efficacy trials in hundreds or thousands, then monitoring after approval · Early safety asks if it harms; only staged larger trials ask if it beats placebo.
- An experiment that assigns the treatment with a control group · Watching spots links, while only assigned treatment shows the drug made the change.